April 22-23, 2024 - Tokyo

The first Summit jointly organized between JAPhMed, PhRMA Japan and MAPS, the Japan Medical Affairs Summit promises to be the most influential annual gathering for Japan’s medical affairs professionals.  New regulatory compliance directives continue to challenge the traditional commercial-driven business environment in Japan and a main goal of the Summit is to help break down the barriers between medical and commercial departments.  The conference draws attendees from all levels- not only from the medical department, but also from other internal stakeholders including R&D, commercial and policy departments.

October 2-4, 2023 - Boston / Cambridge

Building on a nine-year foundation of candid peer-to-peer discussions at the China Healthcare Summit, this year's BioCentury-BayHelix East-West Biopharma Summit will expand beyond the growth of Chinese investment in biopharma, analyzing the core issues China, Asia and Western biotechs must address to become global players.

With 1x1 meetings, Road Show presentations, VIP networking and a strategic program, the BioCentury-BayHelix East-West Biopharma Summit is the perfect opportunity to develop cross-border relationships and advance your global strategy.

September 18, 2024 - Shanghai

AbbVie is seeking to explore exciting new cross-border licensing opportunities with innovative biotechs in China.

This event provides an opportunity to meet with senior research and partnership leadership teams to learn about AbbVie’s partnering strategies and interests.

If you feel your company may be a good fit for potential partnership consideration and would like to share information about your pipeline and discovery platforms, you may apply to meet with senior R&D and Corporate Strategy executives from AbbVie to discuss your ideas and research in a virtual one-on-one setting.

November 8-10, 2023 - Shanghai

The annual CHINATRIALS Summit has established itself as the must-attend industry-focused event for global clinical development executives in China. Since 2021, the Summit has been co-organized with PharmaDJ, a leading media firm with deep connections to China’s innovative biopharma industry. The partnership enables an in-depth event that discusses the key strategies needed to succeed in clinical development both in China and globally.

Launched in 2008, CHINATRIALS brings together 500+ senior-level clinical development executives from multinational and domestic pharmaceutical and biotech companies.

Dates & Location TBA

Organized by the non-profit Consortium of China Healthcare and run entirely by a network of well-connected volunteers, China Healthcare Investment Conference (CHIC) is the premier and longest running event of its kind in China.

CHIC brings together those company executives, entrepreneurs, investors, services providers and government officials interested in and committed to the development of the China healthcare industry.

Launched in 2010, CHIC brings together 550 attendees each year.

Dates TBA - Cambridge, USA

CHINATRIALS+US brings together senior clinical development executives from Chinese innovative biotechs interested in conducting clinical trials in the US and US biotechs who have interest conducting clinical trials in or entering the China market.

The focus of discussion will be on the strategic and technical considerations these companies should consider when entering the US or China markets. We hope the synergies of bringing these two important groups together will introduce new opportunities for partnerships and collaborations for parallel drug development.

Launched in 2019, the event draws 150 attendees each year.

blank-logo.jpg